NO995389L - COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder - Google Patents

COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder

Info

Publication number
NO995389L
NO995389L NO995389A NO995389A NO995389L NO 995389 L NO995389 L NO 995389L NO 995389 A NO995389 A NO 995389A NO 995389 A NO995389 A NO 995389A NO 995389 L NO995389 L NO 995389L
Authority
NO
Norway
Prior art keywords
carprofen
cox
dogs
inflammation
pain
Prior art date
Application number
NO995389A
Other languages
English (en)
Norwegian (no)
Other versions
NO995389D0 (no
Inventor
Kristin Marie Lundby
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO995389D0 publication Critical patent/NO995389D0/no
Publication of NO995389L publication Critical patent/NO995389L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
NO995389A 1997-05-05 1999-11-04 COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder NO995389L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (fr) 1997-05-05 1998-05-01 Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens

Publications (2)

Publication Number Publication Date
NO995389D0 NO995389D0 (no) 1999-11-04
NO995389L true NO995389L (no) 2000-01-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995389A NO995389L (no) 1997-05-05 1999-11-04 COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (fr) * 1998-10-23 2001-08-16 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
ATE306263T1 (de) * 1999-03-10 2005-10-15 Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001087343A2 (fr) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
MXPA02012344A (es) 2000-06-13 2004-02-26 Wyeth Corp Composiciones y anti-inflamatorias que contienen inhibidores cox-2.
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
WO2002012445A1 (fr) 2000-08-07 2002-02-14 Vanderbilt University Detection de l'activite cox-2 et des metabolites d'anandamide
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
JP2007500691A (ja) * 2003-07-31 2007-01-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 抗炎症剤の分散性製剤
BRPI0610316A2 (pt) * 2005-05-20 2010-06-15 Pfizer Ltd combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
CA2685118C (fr) 2007-04-26 2016-11-01 Sigmoid Pharma Limited Fabrication de minicapsules multiples
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
PT3113774T (pt) 2014-03-06 2022-02-28 Elanco Animal Health Incorporated Composições de grapiprant e métodos de utilização das mesmas
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
BR112017014750A2 (pt) * 2015-01-09 2018-06-19 Jaguar Animal Health métodos para tratamento de diarreia em animais de estimação
CN115335046A (zh) * 2020-03-25 2022-11-11 思研（Sri）国际顾问与咨询公司 脂肪氧合酶抑制剂
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
NO995389D0 (no) 1999-11-04
CA2288759A1 (fr) 1998-11-12
PE72599A1 (es) 1999-08-12
EA199900895A1 (ru) 2000-06-26
CN1255059A (zh) 2000-05-31
PL337003A1 (en) 2000-07-31
KR20040004406A (ko) 2004-01-13
HUP0001286A2 (hu) 2000-11-28
AR011726A1 (es) 2000-08-30
ID21311A (id) 1999-05-20
JP2000513020A (ja) 2000-10-03
IL132570A0 (en) 2001-03-19
AP9801234A0 (en) 1999-11-04
HRP980244A2 (en) 1999-02-28
WO1998050033A1 (fr) 1998-11-12
KR20010012300A (ko) 2001-02-15
OA11213A (en) 2003-07-14
PA8450601A1 (es) 2000-05-24
UY24989A1 (es) 2001-10-25
NZ500183A (en) 2002-04-26
BR9808720A (pt) 2000-07-11
EP0988034A1 (fr) 2000-03-29
GT199800063A (es) 1999-10-26
BG103852A (en) 2000-06-30
HUP0001286A3 (en) 2000-12-28
TNSN98059A1 (fr) 2005-03-15
EA003696B1 (ru) 2003-08-28
ZA983722B (en) 1999-11-04
YU55899A (sh) 2003-08-29
IS5220A (is) 1999-10-19
TW590773B (en) 2004-06-11
AU6932198A (en) 1998-11-27
MA26491A1 (fr) 2004-12-20
AR039628A2 (es) 2005-03-02
DZ2479A1 (fr) 2003-02-01
SK148199A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
NO995389L (no) COX-2-selektiv carprofen for behandling av smerte og betennelse i hunder
NO20005190L (no) Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
DE69825447D1 (de) Gerät zur dermatologischen behandlung
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
ID18741A (id) Zat nikotinat dalam terapi
DE69630947D1 (de) Mittel zur schmerzbehandlung
NO20022656L (no) Caspaseinhibitorer og anvendelse derav
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
DE69805438D1 (de) Misch- und ladeöffnung zur medizinischen behandlung
EE9900421A (et) Koduse olmeheitvee puhastussüsteem ja meetod
NO20005179D0 (no) Medikament behandling
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
DE69701250D1 (de) Tierbehandlungsvorrichtung
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
ID24060A (id) Pengolahan kulit hewan yang ditingkatkan
PL354484A1 (pl) Zastosowanie flupirtyny do łagodzenia bólu związanego z chorobami zwyrodnieniowymi stawów u psów i kotów
ITMI20001555A0 (it) Procedimento e dispositivo di trattamento elettrochimico
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
DK0915655T3 (da) Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
AU5388299A (en) Antibodies for use in targeted and temporary treatment of humans and animals
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application